0

Journal Articles

in Drug Therapy
 161-180 of 342 Articles
Capitol Health Call |  January 13, 2010
Price Hikes Probed
Mike Mitka
JAMA. 2010;303(2):125. doi:10.1001/jama.2009.1954.
Medical News & Perspectives |  December 02, 2009
FDA Initiative Aims to Reduce Medication-Related Errors
Bridget M. Kuehn
JAMA. 2009;302(21):2304. doi:10.1001/jama.2009.1759.
Medical News & Perspectives |  November 18, 2009
FDA: Flush Certain Unused Medications
Mike Mitka
JAMA. 2009;302(19):2082. doi:10.1001/jama.2009.1634.
From the Centers for Disease Control and Prevention |  November 04, 2009 FREE
Notice to Readers: Annual Conference on Antimicrobial Resistance—February 1-3, 2010
JAMA. 2009;302(17):1857. doi:.
Medical News & Perspectives |  October 28, 2009
FDA Steps Up Efforts to Find, Remove Violators of Clinical Trial Regulations
Bridget M. Kuehn
JAMA. 2009;302(16):1739-1741. doi:10.1001/jama.2009.1518.
Editorial |  August 26, 2009
Tailoring Antiplatelet Therapy Based on Pharmacogenomics:  How Well Do the Data Fit?
Deepak L. Bhatt, MD, MPH
JAMA. 2009;302(8):896-897. doi:10.1001/jama.2009.1249.
Commentary |  July 08, 2009
FDA Performance Goals for Approving Drugs and Biologics
James Dabney Miller, JD, MPH
JAMA. 2009;302(2):189-191. doi:10.1001/jama.2009.974.
Medical News & Perspectives |  July 08, 2009
NIH Program to Boost Pipeline for Drugs to Treat Rare and Neglected Diseases
Bridget M. Kuehn
JAMA. 2009;302(2):133-134. doi:10.1001/jama.2009.940.
Medical News & Perspectives |  June 24, 2009
FDA Tells Drug and Device Makers to Give Balanced Picture of Risks in Ads, Labels
Bridget M. Kuehn
JAMA. 2009;301(24):2541. doi:10.1001/jama.2009.881.
Capitol Health Call |  June 10, 2009
Enhancing FDA Inspections
Mike Mitka
JAMA. 2009;301(22):2318. doi:10.1001/jama.2009.782.
Capitol Health Call |  May 13, 2009
Unbiased Drug Information
Mike Mitka
JAMA. 2009;301(18):1868. doi:10.1001/jama.2009.606.
Commentary |  February 25, 2009
Promoting More Conservative Prescribing
Gordon D. Schiff, MD; William L. Galanter, MD, PhD
JAMA. 2009;301(8):865-867. doi:10.1001/jama.2009.195.
INCLUDES: CME
Health Agencies Update |  February 25, 2009
Imported Drugs
Bridget M. Kuehn
JAMA. 2009;301(8):817. doi:10.1001/jama.2009.200.
Medical News & Perspectives |  February 11, 2009
Joint Commission Offers Warnings, Advice on Adopting New Health Care IT Systems
Mike Mitka
JAMA. 2009;301(6):587-589. doi:10.1001/jama.2009.37.
Capitol Health Call |  December 10, 2008
Foreign Inspections
Mike Mitka
JAMA. 2008;300(22):2599. doi:10.1001/jama.2008.749.
Capitol Health Call |  December 10, 2008
FDA Preemption
Mike Mitka
JAMA. 2008;300(22):2599. doi:10.1001/jama.2008.751.
Commentary |  November 26, 2008
Benefits and Risks of Drug Treatments:  How to Combine the Best Evidence on Benefits With the Best Data About Adverse Effects
Jan P. Vandenbroucke, MD, PhD; Bruce M. Psaty, MD, PhD
JAMA. 2008;300(20):2417-2419. doi:10.1001/jama.2008.723.
Medical News & Perspectives |  November 19, 2008
New e-Prescribing Guide Unveiled
Bridget M. Kuehn
JAMA. 2008;300(19):2235. doi:10.1001/jama.2008.631.
Research Letters |  November 05, 2008 FREE
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
Joseph S. Ross, MD, MHS; Alexander G. Nazem, BS; Peter Lurie, MD, MPH; et al.
JAMA. 2008;300(17):1998-2000. doi:10.1001/jama.2008.560.
Editorial |  October 22, 2008
Prescription Drugs, Products Liability, and Preemption of Tort Litigation
JAMA. 2008;300(16):1939-1941. doi:10.1001/jama.2008.513.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems